chrisvoncsefalvay/vaers-outcomes huggingface dataset:
presented for Pfizer Covid vaccine,  mother wrote on patient paperwork patients DOB, after administering vaccine it was realized that this was incorrect, making patient too young to receive Covid vaccine.
Information has been received from a health professional concerning a 75 year old female with osteoporosis, rheumatoid arthritis, hypothyroidism, microscopic haematuria and leukopenia with a history of shingles in 1970 and September 2006.  On 10-DEC-2007 she was vaccinated with a 0.7 milliliter dose of ZOSTAVAX (lot# 658398/1087U).  Concomitant therapy included risedronate sodium (ACTONEL) 35 mg, nitrofurantoin (MACRODANTIN) 50 mg once daily, HCTZ/triamterene (DYAZIDE) 25/37.5 mg, levothyroxine sodium (SYNTHROID) 50 mcg, and phentermine 37.5 mg.  On 11-DEC-2007 the patient developed pain on the back, burning sensation on the back and discomfort.  It was reported that the patient called the physician's office and reported that she had been treating herself with gabapentin "that she had" from the September 2006 shingles episode.  At the time of this report, it was reported that the patient had not recovered.  A product quality complaint was not reported.  Additional information has been requested.
Patient passed out after receiving  vaccine. Patient woke up from episode.  Water was giving to patient. He passed out again. Turned pale and green. Eyes rolled back.  Grunted.  Patient woke up from episode. Ambulance/EMT came. Talked to patient. His O2 sat was 97. Patient felt better and left.
Erythema multiform minor-rash present on body surface and some erythema on soft palate. (Raised erythematous plaques all over body, face, palms of hands).
Temperature 102.7F, headache, generalized body weakness for 2 days (12/28 - 12/29). Swollen on left side (injection side). Six days (12/28/02 - 1/3/03). Patien is a medical student; took augmentin 875mg po BID for ? days (prescription by his private doctor). Report this after he returned from India vacation 1/3-1/26. Reported to me on 2/6/03.
104 temp (as reported by mom, not seen in office), red swollen leg x 4d.
Vaccine Card states:  Pfizer Bivalent GH9693 Within 2 days of vaccine, maybe less, I experienced severe water-like clogging in both ears and high-pitched Tinnitus.  I thought perhaps I had ear wax, which I have never had, so I called Facility to schedule an appointment on 10.11.22.  The call was made on 10.11.22 for an appointment on 10.17.22. I had symptoms for a couple of days before I called on 10.11.22.  The nurse tech found zero ear wax and scheduled me for a hearing test prior to an ENT appointment.  I have a CT Sinus scheduled for next week.  Neither I nor apparently the public in general has heard of a possible connection between Tinnitus and ear clogging and the Covid Bivalent vaccine (the first 4 regular Pfizer vaccines caused no problems) until the press reported this, since all previously reporting I have seen has been on long Covid effects, which I do not have.  Consequently, the delay in reporting to VAERS.
The itchiness started in her left eye and it went down to her left mouth; the daughter had a mouth reaction. The itchiness started in her left eye and it went down to her left mouth. It was described as "not the best feeling".; had a reaction in her mouth; she is not feeling the greatest/ not the best feeling; This is a spontaneous report from a contactable reporter, patient's mother.  A 33-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 m-RNA VACCINE, formulation: solution for injection, lot number was not reported) via an unspecified route of administration on 13May2021 (age at vaccination 33-years-old), as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The reporter and the patient had their COVID shots on 13May2021, but the reason the reporter was calling was because her adult daughter and herself went to get the first dosage of the COVID vaccine and everything went fine but while they were waiting after about 5 minutes her daughter had a mouth reaction that was like an itchy feeling on the left side of her mouth and she was not feeling the greatest. She was just sitting still right now. But it started at her left eye and went to the center of her mouth and they talked to the person that was giving the vaccination and they claimed that her daughter was having some kind of a minor reaction because it was something new that was going into her body and the body may respond in different ways. They thought eventually it may go away and they came home. The reporter wanted to know if that adverse event has been reported. The itchiness started in her left eye and it went down to her left mouth and had a mouth reaction, was described as not the best feeling on 13May2021. The outcome of all the event was unknown.  Follow-up attempts are completed. No further information is expected.
On 9/30, agency was notified by an out-of-state health services company that a nurse had reused syringes for multiple person earlier that day at an employee influenza vaccination clinic where the health services company had been contracted. The nurse contracted by the health services company brought three multiple-dose vials of vaccine that were intended for another event (and stored in her personal fridge without temp monitoring). The nurse reported using two syringes she found among her supplies to administer vaccine to 67 employees of the business. She reported wiping the syringes with alcohol and using a new needle for each of the 67 persons. Only 2 multiple dose vials of vaccine (10 doses/vial) were used for 67 adult participants. Participants were offered bloodborne pathogen testing (hep b, hep C, HIV), hepatitis B vaccine, and flu vaccine.
May not be related but I'm not a fan of "coincidence". 8-10 hours after 2nd shot, right pinky & ring finger started feeling numb and not moving normally.  The next morning, those 2 fingers were completely numb and I could not type or write.  The following day, I could feel those 2 fingers but they would not move normally.  There was also a loss of strength such that I was unable to expand my fingers -- such as what you do when opening a pair of closed scissors.  I had to move those 2 fingers with my other hand if I wanted to expand them.  During the following week, the symptoms improved slowly.  By week #2, I could type again but still had some weakness and my hand, wrist, arm tired easily.  At the 3 week mark, I saw an Orthopedic specialist (because I made the appointment the day I couldn't move my fingers) and he had no real explanation.  He said the symptoms I described normally progress the opposite way...starting subtle and progressing to loss of hand/finger function.  Starting with loss of hand/finger function and then it getting better slowly was not something he had seen.  No real treatment or known cause of the problem.  The Orthopedic specialist told me to wear a brace and call if it happens again.
Patient was given the adult dosage of the Pfizer vaccine when she was supposed to receive the (PEDS) pediatric dosage. The local county health department does not carry the pediatric dosage of Pfizer. When I viewed her vaccine card since it showed only that she received Pfizer not that she received the pediatric dosage so I assumed that she was over the age of 12. Patient waited in the lobby 15 minutes after receiving the vaccine and no adverse reaction had occurred.
The initial case was missing the following minimum criteria: Unidentifiable patient. Upon receipt of follow-up information on 27Apr2015, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable consumer, who reported similar events for 2 patients. This is the 2nd of two reports. An elderly patient of an unspecified ethnicity and gender received PREVNAR 13 (Lot # 31687), via an unspecified route of administration on an unspecified date at 0.5 ml, single. Medical history and concomitant medications were not reported. The patient was administered a vaccine that had an issue and got staph infection at the injection site on an unspecified date. The outcome of the events was unknown. The reporter inquired if there are other reports of this lot producing staph infections. They gave the prefilled vaccine and they wore gloves. The reporter also inquired if staph have been obtained from within the assisted living facility or could the medication cause this.
On April 29, 2021 I received the J&J Janssen Covid  vaccine at pharmacy. On December 10, 2021 I received the J&J Janssen Covid Booster vaccine at Pharmacy.  On the morning of January 4, 2022 I awoke with what turned out to be an eye stroke in my right eye - a rare condition called NAION - that has resulted in significant and permanent vision loss in my right eye.
Vaccine had reached working expiration on 6/18/22; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine had reached working expiration on 6/18/22) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis.     Patient had No Known Allergies (NKA).  Concurrent medical conditions included Dementia (Recent changes in condition status: No) since 16-Dec-2020, GERD (Recent changes in condition status: No) since 09-Jan-2019, Hypertension (Recent changes in condition status: No) since 06-Dec-2015, Hyperlipidemia (Recent changes in condition status: No) since 06-Dec-2015 and Chronic kidney disease (Recent changes in condition status: No) since 21-Jun-2022. Concomitant products included MEMANTINE from 16-Dec-2021 to an unknown date for Dementia, OMEPRAZOLE from 16-Dec-2021 to an unknown date for GERD, PRAVASTATIN from 26-Jan-2022 to an unknown date for Hyperlipidemia, FUROSEMIDE from 23-Dec-2021 to an unknown date and HCTZ from 17-Dec-2021 to an unknown date for Hypertension.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 29-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 21-Jun-2022 at 11:00 AM, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 21-Jun-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine had reached working expiration on 6/18/22). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine had reached working expiration on 6/18/22) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The Anatomical location was reported as deltoid for all the three doses of the Moderna vaccine.  It was reported that patient had No adverse reactions.  It was reported that the Booster dose did not undergo any temperature excursions.  No treatment medications reported.
Patient suffered a mechanical fall on steps over 30 minutes after vaccination and sustained a left hip fracture
They received a 0.2 ml from the pink vial instead of the 0.25 ml from the blue cap vial.; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (They received a 0.2 ml from the pink vial instead of the 0.25 ml from the blue cap vial.) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .2 milliliter. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (They received a 0.2 ml from the pink vial instead of the 0.25 ml from the blue cap vial.) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (They received a 0.2 ml from the pink vial instead of the 0.25 ml from the blue cap vial.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (They received a 0.2 ml from the pink vial instead of the 0.25 ml from the blue cap vial.).    This case contains information for the 12th of 24 patients described by the reporter.  No concomitant medications were reported. Patient age was between 6 months to 5-years. The vaccination clinic received incorrect guidance from the Department of Health in regards to the vaccination, who instructed to order and administer the vials with pink top to 6month-5year previously unvaccinated patients when the switch from monovalent to bivalent happened. This resulted in 24 patients being under vaccinated. It was reported that 24 pediatric patients were administered underdose bivalent vaccine doses for either their first or second doses. They received 0.2 ml dose from the pink vial instead of the 0.25 ml dose from the blue cap vial. The patients were being contacted and revaccinated with the correct dose. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-723339 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-723339:Master case
warm to touch ,redness and swelling of entire deltoid and below injection site , itching of arm .Took 2 Benadryl, Same reaction happened after first vaccination but not as significant. Second vaccination symptoms have worsened. I have not required further medical treatment.
pt recvd vax, felt nl until 5PM when temp went up to 103.4;felt sl nauseated, weak & had a severe piercing h/a;took APAP, temp went to 102.6 but wouldn't lower;called ER, to cold shower, take APAP 12NOV95 9AM temp 100, felt much improved
arm was sore; This is a spontaneous report from a non-contactable nurse (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient reported after the first one her arm was sore and then she took some ibuprofen. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     Concomitant products included METFORMIN, HYDROCHLOROTHIAZIDE and METOPROLOL for an unknown indication.    On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills). At the time of the report, CHILLS (chills) outcome was unknown.            No treatment information were reported by the reporter   This case was linked to MOD-2021-402797, MOD-2021-402869 (Patient Link).
SUSPECTED IMMUNOLOGICAL VACCINE FAILURE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient had no known drug or non-drug allergy. The patient had no history of drug abuse or illicit drug use. The patient was non-smoker and non-alcohol user.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805031 expiry: unknown) dose was not reported, administered on 08-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 29-MAR-2021, the patient experienced suspected immunological vaccine failure. Laboratory data included: Antibody test (NR: not provided) Negative Antibodies (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of suspected immunological vaccine failure was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210358301-Covid-19 vaccine ad26.cov2.s-Suspected Immunological Vaccination Failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
I broke out in hives for about 3 weeks. I had the same reaction after my Hepatitis B vaccination.
itchy rash that spread across body, starting on the lower legs and progressing upwards. rash persisted for 2.5 weeks and the dry patches for an additional .5 week.
Runny Nose, headache, joint pain, itching (skin rash in back, chest, face and arms). Every six hours used  two Benadryl for the allergy and  once a day Advil for the pain.
FLARE UP OF DIARRHEA (DIARRHEA  AGGRAVATED); FATIGUE; This spontaneous report received from a patient via a company representative concerned a 69 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: moderate to severe chronic plaque psoriasis, moderate to severe adult crohn's disease, and moderate to severe ulcerative colitis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: unknown) dose was not reported, administered on 20-MAY-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number. Concomitant medications included adalimumab for moderate to severe chronic plaque psoriasis, moderate to severe adult crohn's disease, and moderate to severe ulcerative colitis. On 2021, the patient experienced fatigue. On an unspecified date, the patient experienced flare up of diarrhea (diarrhea aggravated). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from flare up of diarrhea (diarrhea aggravated), and the outcome of fatigue was not reported. This report was non-serious.
Pfizer-BioNTech COVID-19 Vaccine  On 2nd day 8 am was very very tired and took several naps.  Lasted for about 8 hours.  Took ibuprofen at 10 am.
Swollen hands and face then on third day with face red and burning sensation, and red on neck. Also Gerd. Two dose steroid, benadryl as needed, Pepcid as needed. Hands and face still some swelling
This patient presented to the office on February 3, 2022 complaining of painful bumps under the skin on both of her shins and some on her calves. She has had no other symptoms such as sore throat or cough. she has no fever. The rash is localized to the pre-tibial regions and is said to be painful to touch. diagnosis of Erythema Nodosum was made
This spontaneous report has been received from a licensed practical nurse referring to a 17 year old patient of unknown gender. Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications were not reported. In April 2018, the patient was vaccinated with improperly stored vaccine of GARDASIL 9 lot # N025428 with expiration date of 19-JUN-2020 (strength, dose, route, and anatomical location were not provided) for prophylaxis. The vaccine was exposed to a temperature excursion below 32 degree Fahrenheit (31.1 degree F) for 8 hours and 27 minutes, also between 32 degree F to 35 degree F (32.5 degree F) for 4 hours and 33 minutes, which were called by a data logger. No adverse events were reported. Product quality control issue was not involved. This is one of the 46 reports from the reporter.
Information has been received from a physician's assistant who reports an office had several patients faint after receiving GARDASIL. It was unknown exactly how many patients or time frame involved. The outcome of the patients was unknown. Follow up information was received from a office manager who said that their office was aware that "patients might faint when they get their GARDASIL vaccine" and that "patients faint all the time", therefore she was uncertain for the reason of the original report. She explained that details regarding individual patients would have to be discussed with the physician or physician's assistant upon their return. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available.
Information has been received from a physician's assistant concerning a female patient with no pertinent medical history and no drugs reactions or allergies who on 15-SEP-2010 was vaccinated with a dose of PNEUMOVAX 23 (Lot # unknown). There was no concomitant medication. The physician's assistant reported that on 16-SEP-2010 "within 24 hours after received the vaccine" the patient developed fever, a large welt at the injection point and redness. No laboratory diagnostics studies were performed. At the time of report, the patient's outcome was unknown. The patient sought unspecified medical attention. Follow up information has been received from the medical assistant concerning a 43 year old female patient with viral sinusitis at the time of vaccination, with asthma, Polycythaemia rubra vera, and drug allergy (TYLENOL) who on 15-SEP-2010 was vaccinated with a dose of PNEUMOVAX 23 (Lot # 667418/0978Z) in the right arm. It was reported that on 15-SEP-2010, the patient developed 3-5 days of febrile illness, generalized myalgias, injection site tenderness and diffuse with diffuse swelling and erythema of involved deltoid/triceps. The patient sought medical attention at doctor visit. It was reported that on approximately 20-SEP-2010 the patient recovered from the febrile illness, generalized myalgias, injection site tenderness with diffuse swelling and erythema of involved deltoid/triceps. No relevant diagnostic test was performed. Additional information is not expected.
Two days after his first vaccination he had increased pain in b/l hips, knees and ankles. Had severe swelling in both ankles. He had a similar response to his 2nd dose, but not as intense. The pain and swelling has persisted since then.
devel red blotches & took to MD 17JUL AM began vomiting & diarrhea then fever followed up to 101.7 sick all noc; stopped vomiting @ 6AM still had fever 101.7; pt reacted to DTP @ 6mos of age; family hx of reaction to DTP w/mom & cousin;
Recieved message from patient on October 20th that she has had shoulder pain since the injection was provided. She reports decrease range of motion, difficulty lifting and sleeping. She has schedule a PCP appointment for 10/22/15. Left message with patient on 10/21 to discuss message further.
Developed abdominal pain, nausea, vomiting and diarrhea and was diagnosed with acute pancreatitis. Had no prior history. Does not use alcohol or illicit drugs. Developed chronic pancreatitis in the year following initial diagnosis. Resulted in 90 pound weight loss since diagnosis. Required draining of pancreatic cyst and placement of stents.